Following concerns about potential cybersecurity vulnerabilities on certain Abbott Laboratories Inc. implantable cardiac devices, US FDA has alerted patients and health-care providers to another firmware rolled out by the company to mitigate those risks. The firmware also tackles problems with premature battery depletion, which the agency says is unrelated to the cybersecurity concerns.
Abbott Issues New Cybersecurity Patch For Cardiac Devices
After Abbott recently settled a case against short-seller Muddy Waters, the company has put out a second cybersecurity patch for certain St. Jude radio-frequency enabled cardiac devices to stop potential hackers from harming patients.
More from Cybersecurity
More from Digital Technologies
• By
Recognizing that the evidence it receives in applications for health technology assessments will increasingly be informed by artificial intelligence, the CDA-AMC has clarified its expectations for companies that use AI methods in the generation and/or reporting of evidence.
• By
Medtronic says results from a recent study on the Hugo robotic-assisted surgery system substantiate its safety and effectiveness for various urological procedures. The company also announced it has submitted the system to the FDA for approval for a urological indication.
• By
Diabetes company Insulet announced that former longtime J&J executive Ashley McEvoy will succeed Jim Hollingshead as president and CEO effective today. Analysts applauded the appointment, noting McEvoy’s strong background in medtech and diabetes.